From GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters
What does it really take to recreate one of today’s most talked-about medicines? As semaglutide gains traction worldwide,…
My Mother Had Alzheimer’s. That’s Why I Started a GLP-1
As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
Nutrition matters for GLP-1 drug users
We noticed it right away in 2005 when the first GLP-1 medication for people with diabetes hit the…
Ozempic Weight Loss: From willpower to prescriptions: How Ozempic is rewriting the weight-loss story
There is a moment, somewhere between a celebrity rumour and a viral before-and-after, when a drug stops being…
Keeping rebound weight off after stopping GLP-1 drugs
For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
GLP-1 Drugs May Trigger Muscle Loss In Cirrhosis Patients: Study
Drugs from the GLP-1 receptor agonist class, widely used for diabetes and weight loss, are now under scrutiny…
New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
Treatment for diabetes and obesity is rapidly evolving, with multi-targeted approaches taking shape. Medications like semaglutide, a glucagon-like…
Should you take GLP-1 drugs for longevity?
This is, indeed, part of a wider trend of mutual support at the fringes of pharmacology, with similar…